用针对蛋白质合成的抗菌药物治疗皮索斯:概述
Erico S Loreto1, Juliana S M Tondolo1, Régis A Zanette2
1Sobresp Faculty of Health Sciences, 520 Appel Street, Santa Maria 97015-030, RS, Brazil.
Journal of fungi (Basel, Switzerland)
|April 26, 2024
概括
针对蛋白质合成的抗菌药物显示出治疗皮索斯 (Pythium insidiosum感染) 的前景. 将这些药物与手术结合起来,有可能为有效的皮索西斯治疗提供潜力.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 皮修斯病是一种严重的感染,由虫Pythium insidiosum引起.
- 皮索斯症的治疗选择有限,并且往往具有挑战性.
- 针对蛋白质合成的抗菌药物已在体外显示出对P. insidiosum的活性.
研究的目的:
- 审查抑制蛋白质合成的抗菌药物对Pythium insidiosum的疗效.
- 评估这些药物在治疗pythiosis.is中的潜力.
- 确定当前研究中的差距,并建议未来的方向.
主要方法:
- 在体外研究,实验性感染模型和临床病例报告的文献综述.
- 对P. insidiosum对宏类,氧利丁和四环素的敏感性数据的分析.
- 综合发现,以评估治疗潜力.
主要成果:
- 在Pythium insidiosum表现出对宏类,氧利丁类和四环素的敏感性.
- 这些抗菌药物显示出对治疗皮索斯的潜力,特别是当与外科除菌一起使用时.
- 有证据表明,这些药物在组合治疗中起着作用.
结论:
- 蛋白质合成抑制剂代表了对pythiosis的可行的治疗选择.
- 个性化治疗策略和进一步的研究对于优化皮索西斯管理至关重要.
- 需要标准化测试方案和进一步的临床研究来确认疗效.
更多相关视频
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
1.6K
11:00Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
8.3K
相关概念视频
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Lytic Cycle of Bacteriophages
70.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.6K
Types of RNA
63.6K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.6K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
379
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
379
Antibiotic Selection
53.3K
Overview
53.3K
